The Breast Cancer Liquid Biopsy market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Breast Cancer Liquid Biopsy industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Breast Cancer Liquid Biopsy market can be split based on product types, major applications, and important countries as follows:
Key players in the global Breast Cancer Liquid Biopsy market covered in Chapter 12:
Menarini Silicon Biosystems
Thermo Fisher Scientific Inc
Myriad Genetics, Inc
Biodesix, Inc
Cynvenio Biosystems, Inc
Illumina, Inc
Isogen Life Science
FLUXION BIOSCIENCES
Genomic Health
GUARDANT HEALTH, INC
In Chapter 4 and 14.1, on the basis of types, the Breast Cancer Liquid Biopsy market from 2015 to 2025 is primarily split into:
Circulating Tumor Cells (CTCs)
Cell-free DNA (cfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
In Chapter 5 and 14.2, on the basis of applications, the Breast Cancer Liquid Biopsy market from 2015 to 2025 covers:
Reference Laboratories
Hospitals and Physician Laboratories
Other End Users
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Breast Cancer Liquid Biopsy Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Breast Cancer Liquid Biopsy
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Breast Cancer Liquid Biopsy industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Breast Cancer Liquid Biopsy Market Size, 2015 - 2020
2.1.2 Global Breast Cancer Liquid Biopsy Market Size by Type, 2015 - 2020
2.1.3 Global Breast Cancer Liquid Biopsy Market Size by Application, 2015 - 2020
2.1.4 Global Breast Cancer Liquid Biopsy Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Breast Cancer Liquid Biopsy Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Breast Cancer Liquid Biopsy Analysis
3.2 Major Players of Breast Cancer Liquid Biopsy
3.3 Breast Cancer Liquid Biopsy Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Breast Cancer Liquid Biopsy
3.3.3 Labor Cost of Breast Cancer Liquid Biopsy
3.4 Market Distributors of Breast Cancer Liquid Biopsy
3.5 Major Downstream Buyers of Breast Cancer Liquid Biopsy Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Breast Cancer Liquid Biopsy Market, by Type
4.1 Global Breast Cancer Liquid Biopsy Value and Market Share by Type (2015-2020)
4.2 Global Breast Cancer Liquid Biopsy Production and Market Share by Type (2015-2020)
4.3 Global Breast Cancer Liquid Biopsy Value and Growth Rate by Type (2015-2020)
4.3.1 Global Breast Cancer Liquid Biopsy Value and Growth Rate of Circulating Tumor Cells (CTCs)
4.3.2 Global Breast Cancer Liquid Biopsy Value and Growth Rate of Cell-free DNA (cfDNA)
4.3.3 Global Breast Cancer Liquid Biopsy Value and Growth Rate of Extracellular Vesicles (EVs)
4.3.4 Global Breast Cancer Liquid Biopsy Value and Growth Rate of Other Circulating Biomarkers
4.4 Global Breast Cancer Liquid Biopsy Price Analysis by Type (2015-2020)
5 Breast Cancer Liquid Biopsy Market, by Application
5.1 Downstream Market Overview
5.2 Global Breast Cancer Liquid Biopsy Consumption and Market Share by Application (2015-2020)
5.3 Global Breast Cancer Liquid Biopsy Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Breast Cancer Liquid Biopsy Consumption and Growth Rate of Reference Laboratories (2015-2020)
5.3.2 Global Breast Cancer Liquid Biopsy Consumption and Growth Rate of Hospitals and Physician Laboratories (2015-2020)
5.3.3 Global Breast Cancer Liquid Biopsy Consumption and Growth Rate of Other End Users (2015-2020)
6 Global Breast Cancer Liquid Biopsy Market Analysis by Regions
6.1 Global Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Regions
6.1.1 Global Breast Cancer Liquid Biopsy Sales by Regions (2015-2020)
6.1.2 Global Breast Cancer Liquid Biopsy Revenue by Regions (2015-2020)
6.2 North America Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
6.3 Europe Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
6.6 South America Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
7 North America Breast Cancer Liquid Biopsy Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries
7.2.1 North America Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)
7.2.2 North America Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
7.3 United States Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
7.4 Canada Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
7.5 Mexico Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
8 Europe Breast Cancer Liquid Biopsy Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries
8.2.1 Europe Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)
8.2.2 Europe Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
8.3 Germany Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
8.4 UK Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
8.5 France Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
8.6 Italy Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
8.7 Spain Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
8.8 Russia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
9 Asia Pacific Breast Cancer Liquid Biopsy Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)
9.2.2 Asia Pacific Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
9.3 China Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
9.4 Japan Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
9.5 South Korea Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
9.6 India Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
9.8 Australia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
10 Middle East and Africa Breast Cancer Liquid Biopsy Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
10.3 Saudi Arabia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
10.4 UAE Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
10.5 Egypt Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
10.6 Nigeria Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
10.7 South Africa Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
11 South America Breast Cancer Liquid Biopsy Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries
11.2.1 South America Breast Cancer Liquid Biopsy Sales by Countries (2015-2020)
11.2.2 South America Breast Cancer Liquid Biopsy Revenue by Countries (2015-2020)
11.3 Brazil Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
11.4 Argentina Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
11.5 Columbia Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
11.6 Chile Breast Cancer Liquid Biopsy Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Menarini Silicon Biosystems
12.1.1 Menarini Silicon Biosystems Basic Information
12.1.2 Breast Cancer Liquid Biopsy Product Introduction
12.1.3 Menarini Silicon Biosystems Production, Value, Price, Gross Margin 2015-2020
12.2 Thermo Fisher Scientific Inc
12.2.1 Thermo Fisher Scientific Inc Basic Information
12.2.2 Breast Cancer Liquid Biopsy Product Introduction
12.2.3 Thermo Fisher Scientific Inc Production, Value, Price, Gross Margin 2015-2020
12.3 Myriad Genetics, Inc
12.3.1 Myriad Genetics, Inc Basic Information
12.3.2 Breast Cancer Liquid Biopsy Product Introduction
12.3.3 Myriad Genetics, Inc Production, Value, Price, Gross Margin 2015-2020
12.4 Biodesix, Inc
12.4.1 Biodesix, Inc Basic Information
12.4.2 Breast Cancer Liquid Biopsy Product Introduction
12.4.3 Biodesix, Inc Production, Value, Price, Gross Margin 2015-2020
12.5 Cynvenio Biosystems, Inc
12.5.1 Cynvenio Biosystems, Inc Basic Information
12.5.2 Breast Cancer Liquid Biopsy Product Introduction
12.5.3 Cynvenio Biosystems, Inc Production, Value, Price, Gross Margin 2015-2020
12.6 Illumina, Inc
12.6.1 Illumina, Inc Basic Information
12.6.2 Breast Cancer Liquid Biopsy Product Introduction
12.6.3 Illumina, Inc Production, Value, Price, Gross Margin 2015-2020
12.7 Isogen Life Science
12.7.1 Isogen Life Science Basic Information
12.7.2 Breast Cancer Liquid Biopsy Product Introduction
12.7.3 Isogen Life Science Production, Value, Price, Gross Margin 2015-2020
12.8 FLUXION BIOSCIENCES
12.8.1 FLUXION BIOSCIENCES Basic Information
12.8.2 Breast Cancer Liquid Biopsy Product Introduction
12.8.3 FLUXION BIOSCIENCES Production, Value, Price, Gross Margin 2015-2020
12.9 Genomic Health
12.9.1 Genomic Health Basic Information
12.9.2 Breast Cancer Liquid Biopsy Product Introduction
12.9.3 Genomic Health Production, Value, Price, Gross Margin 2015-2020
12.10 GUARDANT HEALTH, INC
12.10.1 GUARDANT HEALTH, INC Basic Information
12.10.2 Breast Cancer Liquid Biopsy Product Introduction
12.10.3 GUARDANT HEALTH, INC Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Breast Cancer Liquid Biopsy Market Forecast
14.1 Global Breast Cancer Liquid Biopsy Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Circulating Tumor Cells (CTCs) Market Value and Volume Forecast (2020-2025)
14.1.2 Cell-free DNA (cfDNA) Market Value and Volume Forecast (2020-2025)
14.1.3 Extracellular Vesicles (EVs) Market Value and Volume Forecast (2020-2025)
14.1.4 Other Circulating Biomarkers Market Value and Volume Forecast (2020-2025)
14.2 Global Breast Cancer Liquid Biopsy Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Reference Laboratories Market Value and Volume Forecast (2020-2025)
14.2.2 Hospitals and Physician Laboratories Market Value and Volume Forecast (2020-2025)
14.2.3 Other End Users Market Value and Volume Forecast (2020-2025)
14.3 Breast Cancer Liquid Biopsy Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter
Global Personal Car Leasing Market Resea..
The report focuses on the Personal Car Leasing market size, ..
+16467917070US (Toll Free)